CBL_dyspepsia Flashcards
What is dyspepsia? (definition)
Dyspepsia = a range of upper gastrointestinal (GI) symptoms l_asting 4 weeks_ or more including heartburn (burning retrosternally), indigestion, upper abdominal pain or discomfort, gastric reflux, nausea or vomiting.
Definition of the following symptoms:
- heartburn
- gastric reflux
•Heartburn
–Typically a burning retrosternal sensation
•Gastric Reflux
–Describes the movement of stomach contents (usually acid) into the oesophagus
Definition of the following symptoms:
- indigestion
- dysphagia
- odynophagia
•Indigestion
–Pain or discomfort in the stomach associated with difficulty digesting food
•Dysphagia
–Difficulty swallowing
•Odynophagia
–Painful swallowing
What’s functional dyspepsia?
Functional dyspepsia
One or more of:
- Bothersome postprandial (after meal) fullness
- Early satiety
- Epigastric pain
- Epigastric burning
And: No evidence of structural disease (including normal OGD) that is likely to explain the diagnosis
What’s GORD?
Gastro Oesophageal**Reflux Disease (GORD)
–A condition which develops when the reflux of gastric content causes troublesome symptoms
The differential diagnosis for dyspepsia
Dyspepsia differentials
- GORD (A condition which develops when the reflux of gastric content causes troublesome symptoms)
- Peptic/duodenal ulcer disease
- Gastritis
- Duodenal obstruction (e.g. pancreatic malignancy)
- Gallbladder disease/Gallstones
- Hiatus hernia = sliding vs oesophageal
- Medication (NSAIDs, bisphosphonates, Ca2+ channel blockers, steroids)
- Functional dyspepsia
- IBS/IBD
- Eosinophilic oesophagitis = autoimmune - allergy to precipitating foods
- Cardiac causes
- Cancers (oesophageal, gastric, pancreatic)
Initial consideration in management in the patient with dyspepsia
(3 likely scenarios)
Consider if:
A. Patient needs an urgent OGD (oesophago-gastroduodenoscopy) -> if there is any GI bleed: hematemesis or malena -> refer to hospital
B. Red flag symptoms -> 2 weeks referral cancer pathway
C. If not above -> consider most likely clinical diagnosis and trial of treatment
Who to refer for direct access (2 weeks wait) upper GI endoscopy?
•With dysphagia
•Aged 55 and over with weight loss and any of the following:
–Upper abdominal pain
–Reflux
–Dyspepsia
In what group of patients (age and symptoms) we consider non-urgent direct access upper GI endoscopy?
(2 weeks oesophageal cancer referral)
Patients 55 years old or more
Symptoms:
- failed dyspepsia treatment
- upper abdo pain + anaemia
- raised platelets + nausea/vomiting/weight loss/reflux/dyspepsia/upper abdo pain
- N+V + weight loss/reflux/dyspepsia/upper abdo pain
Dyspepsia management
- lifestyle advice
Lifestyle advice:
- No spicy, citrus foods
- No smoking/alcohol
- Lose weight
- No lying down after meals
H. Pylori
- type of an organism
- transmission
H. Pylori:
- gram negative bacteria (rod shaped)
- oral-faecal or oral-oral route
-
H. Pylori
- is it usually symptomatic?
- 90% of patients do not have symptoms
What diseases does H. Pylori increase the risk of?
- gastric cancer
- doudenal ulcer
- gastric ulcer
Investigations for H. Pylori
H. pylori testing
- Breath test: looks at breakdown of urea in breath (urease activity by the bacteria) - requires 2+ weeks off PPI
- Faecal antigen test
- Biopsy on OGD (multiple biopsies)
Treatment for H. Pylori
_H. pylori treatmen_t
Triple therapy: Amoxicillin + metronidazole + PPI
for 2 weeks
Management of dyspepsia (pharmacological classes)
A. H. pylori testing -> if negative start treatment (below)
B. PPI for 4-8w
C. If symptoms reoccur - low dose PPI, H2A - PRN
D. Consider H2 receptor antagonist therapy if there is an inadequate response to PPI
*Probably should be reviewing the diagnosis and the need for endoscopy at this point
What are the components of Gaviscon?
Sodium alginate and sodium bicarbonate
Mechanism of action of Gaviscon and its components
- Anti-acid -> it is alkali based; neutralises the gastric acid -> symptoms relief
- Alginate -> forms a protective layer that floats on the top of gastric content
Mode of action of Histamine 2 Receptor Antagonist? (in terms of dyspepsia)
Examples of H2RA drugs
Mode of action:
- Histamine (H2) stimulates parietal cells to produce gastric acid
- H2RA competitively block this receptor -> decrease in gastric acid production
Examples: Cimetidine, Ranitidine, Famotidine
Side effects of H2 receptor antagonists
Side effects:
- Cimetidine > Ranitidine > others -> inhibit cytochrome P450 pathway
- Diarrhoea, headache, dizziness, rash
- Increased risk of pneumonia
PPI
- mode of action
- examples of drugs
Mode of action of PPI:
- Irreversibly inhibit the proton pump (H+/K+/ATPase) of the gastric parietal cells
- Stops H+ ions from being secreted into the gastric lumen
•Reduces acid production by 95-99%
Examples: Omeprazole, Lansoprazole, Pantoprazole
General side effects of PPI
General side effects PPI
•Nausea, vomiting, abdominal pain, flatulence, diarrhoea, constipation and headache
Concerns associated with PPI use
Specific PPI Concerns
- Increased risk of Clostridium difficile infection (and recurrence)
- Osteoporosis (long term use)
- Pneumonia
- Rebound acid hyper-secretion (after stopping)
- Iron deficiency anaemia
- Electrolyte disturbance (Mg/Ca/K)
- Microscopic colitis
- Drug induced Subacute Cutaneous Lupus Erythematosus (SCLE)
*generally PPI are safe to use, but try to minimase a long-term and large dose use
Risk factors and associations in gastric ulcer
Gastric ulcers
- Middle aged/older aged population
- Pain worse with food
- Gastro-toxic medications often implicated (Aspirin/NSAIDs/Steroids) & smoking
- H.Pylori implicated in >60%
- Malignancy must be considered 1-2%
Risk factors and associations with duodenal ulcers
Duodenal ulcers
- Younger and usually male
- Food relieves the pain
- Nocturnal pain more common
- H.Pylori implicated in >90%
- Malignancy is very rare
Examples of rare ulcers
- Gastrinoma/Zollinger Ellison Syndrome
- Crohn’s disease